Generic Sweden (GENI) Q2 2024 earnings summary

Executive summary

• Revenue grew 25% year-over-year in Q2 2024, reaching 43.41 MSEK, driven by strong new sales and expansion among existing customers.

• EBITDA decreased slightly by 0.1 MSEK to 6.97 MSEK, with EBITDA margin at 16% versus 21% last year.

• Net income per share was 0.44 SEK, nearly flat compared to 0.45 SEK in Q2 2023.

• The company signed 92 new customer agreements in the quarter, with growth led by e-commerce, healthcare, and public sector segments.

• Implementation of Inera services completed, and Apple’s support for RCS expected to open new business opportunities.

Financial highlights

• Q2 2024 revenue: 43.41 MSEK (up 25% year-over-year); H1 2024 revenue: 85.58 MSEK (up 24%).

• Q2 2024 EBITDA: 6.97 MSEK (down 2% year-over-year); H1 2024 EBITDA: 14.11 MSEK (down 4%).

• Q2 2024 net income: 5.38 MSEK; H1 2024 net income: 10.96 MSEK.

• Q2 2024 operating cash flow: -2.34 MSEK (vs. 12.41 MSEK last year), impacted by timing of customer payments.

• Total liquidity at period end: 26.3 MSEK, including 13.3 MSEK in cash and 13 MSEK in short-term investments.

Outlook and guidance

• Market demand for digital communication services remains strong, with continued growth expected in e-commerce, healthcare, and public sector.

• Anticipated full support for RCS messaging on iOS and Android to drive new business opportunities.

• Ongoing price adjustments and increased investment in development and sales to support future growth.